FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
3,819 letters. Newest first.
-
DrugsZenzi Pharmaceutical Industries Pvt. Ltd.
Zenzi Pharmaceutical Industries refused FDA requests for records about prescription drugs made for the U.S. market.
High risk -
DrugsMarshalls Traditional Healthcare CC
Marshalls Traditional Healthcare, an OTC drug maker in South Africa, lacked finished-product release testing and process validation.
High risk -
DrugsABR Laboratory LLC
FDA warned ABR Laboratory, a contract drug testing lab, that unverified microbial test methods and missed investigations made tested drugs adulterated.
High risk -
DrugsTyche Industries Ltd
FDA warned Tyche Industries over falsified records, dirty equipment, and untested raw materials at its API plant.
High risk -
DrugsJagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals cited for API CGMP and listing failures after Indian inspection, leading to US import alert.
High risk -
DrugsAmWiner & Raphe Holdings, LLC dba rapheGenerics Corp
FDA cited rapheGenerics for manufacturing-quality failures and unapproved minoxidil hair regrowth drugs.
High risk -
DevicesRobbins Instruments, LLC
Robbins Instruments marketed Dermo-Jet Needleless Injector without FDA clearance and had quality system violations.
High risk -
TobaccoGorilla Vapes of East Brunswick
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsChengdu Innovation Pharmaceutical Co., Ltd.
FDA warned Chengdu Innovation Pharmaceutical over CGMP (manufacturing quality rules) failures in API (drug ingredient) manufacturing, including no identity testing of incoming materials.
High risk -
DrugsWuhu Nuowei Chemistry Co., Ltd.
FDA cited Wuhu Nuowei Chemistry for API CGMP deviations in impurity testing, stability data, and cleaning, and placed products on import alert.
High risk -
DrugsISOThrive, Inc.
ISOThrive ran two human studies of a supplement used as a drug without submitting a required IND.
High risk -
DrugsStrukmyer LLC dba Strukmyer Medical
Strukmyer Medical was cited for current good manufacturing practice violations after FDA found repeated microbial contamination in water used to make OTC drugs.
High risk -
DrugsShantou Kangjie Daily Chemical Industry Co., Ltd
FDA warns Shantou Kangjie over CGMP failures for OTC drugs, including untested ethanol and no quality unit.
High risk -
DrugsImperial Palace Commodity -Dongguan- Co., Ltd.
FDA warns Chinese maker of OTC alcohol wipes that weak component testing and process validation make its drugs adulterated.
High risk -
DrugsCenter for Instrumental Analysis of China Pharmaceutical University
Center for Instrumental Analysis of China Pharmaceutical University cited for incomplete API testing records and no quality unit.
High risk -
BiologicsBioStem Life Sciences
FDA says BioStem Life Sciences made unapproved umbilical cord and amniotic products with significant CGMP violations.
High risk -
DrugsGlobal Calcium Pvt. Limited
FDA cites Global Calcium API plant for falsified records, deleted files, facility leaks and incomplete impurity profiles; products on Import Alert 66-40.
High risk -
FoodTalla Imports, LLC
FDA says Talla Imports lacked required foreign supplier safety plans for Swedish toffee, cookies and candy.
Medium -
DrugsFagron Compounding Services, LLC dba Fagron Sterile Service
FDA warns Fagron Sterile Services about unsafe sterile drug production and labeling problems at its Wichita facility.
High risk -
DrugsKardesler Ucan Yaglar Sanayi Anonim Sirketi
Turkey-based OTC drug maker Kardesler Ucan failed to test glycerin, propylene glycol and ethanol for dangerous impurities and is on US import alert.
High risk -
BiologicsChara Biologics, Inc.
FDA warns Chara Biologics over unapproved, unlicensed CharaExo, CharaCore, CharaOmni.
High risk -
DrugsMihon Corp. d/b/a VitalityVita and Boulla, LLC
FDA warns Mihon Corp./Boulla that VitalityXtra, PeakMax, ZapMax and ZoomMax supplements contain hidden sildenafil and diclofenac and are unapproved, misbranded drugs.
High risk -
BiologicsEvolutionary Biologics Inc.
FDA warned Evolutionary Biologics that its exosome and umbilical-cord products are unapproved new drugs and unlicensed biologics sold with disease-treatment claims.
High risk -
DrugsSanofi
FDA warned Sanofi subsidiary Genzyme over manufacturing quality failures at its Framingham, MA API plant.
High risk -
Drugswww.weightcrunchshop.com
FDA warned www.weightcrunchshop.com about selling unapproved and misbranded semaglutide and oxycodone drugs to U.S. consumers online.
High risk -
DrugsAtlanta Supersource, Inc.
Atlanta Supersource made OTC hand sanitizers on equipment shared with toxic industrial chemicals and lacked testing, FDA says.
High risk -
FoodNyumbani Hakuna Matata LLC
FDA warns Buffalo seafood importer Nyumbani Hakuna Matata over missing safety checks for dried fish from Tanzania.
High risk -
FoodCOFISA - Conservas de Peixe da Figueira, S.A.
FDA found COFISA's canned sardine and tuna food-safety plans inadequate, with missing hazards and weak histamine (spoilage toxin) controls.
High risk -
FoodPremium Fresh Growers LLC
FDA warns Premium Fresh Growers it lacked required foreign supplier checks for imported limes, cilantro, and carrots.
Medium -
DrugsINCELL Corporation LLC
FDA warned INCELL Corporation for making an unapproved amniotic-fluid drug without validating its sterile manufacturing process.
High risk -
FoodDuong Ha Processing Trading Seafood Company Limited
FDA warns Vietnam seafood processor Duong Ha over HACCP failures for frozen scombrotoxin-forming fish.
High risk -
FoodSalt City Baking Company, LLC
FDA says Salt City Baking's ready-to-eat bread was made under insanitary conditions, with insects, mold and missing food-safety controls.
High risk -
FoodWestern Innovations, Inc.
FDA warns Western Innovations over manufacturing-rule violations in Acetyl-glutathione supplements after Denver inspection.
Medium -
FoodMiyajima Shoyu Co., Ltd.
Miyajima Shoyu lacked FDA-filed scheduled processes for acidified Wasabi Dressing, making it adulterated.
High risk -
TobaccoMidwest Goods Inc., d/b/a Midwest Distribution and Midwest Distribution Illinois
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
FoodBy George Food Specialties Inc.
By George Food Specialties lacked required foreign supplier verification program for imported mayonnaise and hot sauce, FDA says.
Medium -
DevicesIntegra LifeSciences Corporation
FDA warned Integra LifeSciences over bacterial toxin test and sterilization failures at three medical device plants.
High risk -
DevicesHologic, Inc.
FDA warns Hologic over design-control and reporting failures for implantable BioZorb markers, including missed medical device reports and a correction report.
High risk -
DevicesXoran Technologies, LLC
FDA warned Xoran Technologies that its computed tomography devices and software violate quality rules and lack required marketing clearance.
High risk -
DevicesPhillips Precision, Inc.
FDA says Phillips Precision, a contract maker of orthopedic implants and instruments, violated device quality rules for cleaning and process controls.
High risk -
DevicesRandox Laboratories Limited
FDA warned Randox Laboratories over inadequate risk analysis and corrective actions for carryover errors in RX series analyzers.
High risk -
TobaccoReedhill Ventures LLC, d/b/a Vape On
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoElite Brothers, LLC
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoEcig Charleston LLC
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsIndoco Remedies Limited
FDA warned Indoco Remedies over manufacturing quality failures at its Goa plant, including unreliable microbial testing and aseptic processing deficiencies.
High risk -
BiologicsXO Biologix, LLC
XO Biologix markets MaviX, an amniotic-fluid product, as an unapproved new drug and unlicensed biologic.
High risk -
FoodCandymar Produce Inc
Candymar Produce, a Texas importer, had no FSVP for imported carrots, squash and cabbage, FDA found.
Medium -
AnimalEvolution Pets LLC
Evolution Pets marketed SeizureGuard Plus and Life Span Arthritis & Mobility as unapproved drugs for treating dog diseases.
High risk -
AnimalNutrition Strength Ltd.
FDA warns Nutrition Strength Ltd. over unapproved dog seizure and blood-support supplements marketed as animal drugs.
High risk -
AnimalEnergetic Essences, LLC dba Pet Essences
FDA warned Pet Essences that its Seizures formula is an unapproved new animal drug marketed to treat seizures in animals.
High risk